Metropolitan Life Insurance Company (MetLife)’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-6,182
Closed -$121K 1607
2024
Q1
$121K Sell
6,182
-298
-5% -$6.29K 0.01% 956
2023
Q4
$149K Hold
6,480
0.01% 879
2023
Q3
$149K Buy
6,480
+2,760
+74% +$70.2K 0.01% 817
2023
Q2
$97.1K Buy
3,720
+896
+32% +$23.7K ﹤0.01% 1034
2023
Q1
$78K Buy
2,824
+42
+2% +$1.11K ﹤0.01% 1137
2022
Q4
$63.2K Hold
2,782
﹤0.01% 1330
2022
Q3
$94.8K Hold
2,782
﹤0.01% 1050
2022
Q2
$81K Hold
2,782
﹤0.01% 1192
2022
Q1
$74.4K Sell
2,782
-3,259
-54% -$76.9K ﹤0.01% 1381
2021
Q4
$156K Hold
6,041
﹤0.01% 2196
2021
Q3
$142K Hold
6,041
﹤0.01% 2312
2021
Q2
$268K Buy
+6,041
New +$223K ﹤0.01% 1946

Other funds holding PRVA

Metropolitan Life Insurance Company (MetLife)'s PRVA Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Privia Health (PRVA) in Q2 2024, closing a stake of 6,182 shares — an estimated $121K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in PRVA in Q2 2021 and held it in 12 quarters. The position peaked at $268K in Q2 2021. 225 funds tracked by Wall St. Rank hold PRVA as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Privia Health position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 6,182 Privia Health shares in Q2 2024, an estimated $121K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Privia Health in Q2 2021 and held it in 12 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Privia Health position peaked at $268K in Q2 2021.
  • 225 funds tracked by Wall St. Rank held Privia Health as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.